{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:27:38Z","timestamp":1791430058360,"version":"4.3.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["82203045"],"award-info":[{"award-number":["82203045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Social Development Project","award":["BE2021745"],"award-info":[{"award-number":["BE2021745"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biotechnol"],"DOI":"10.1186\/s12896-026-01160-y","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:04:48Z","timestamp":1778749488000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["B3GNT6 suppresses colorectal cancer progression by inhibiting the KRAS\/ERK signaling pathway"],"prefix":"10.1186","volume":"26","author":[{"given":"Changwen","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuetong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"1160_CR1","doi-asserted-by":"crossref","unstructured":"Zygulska AL. Pierzchalski P. Novel diagnostic biomarkers in colorectal cancer [J]. Int J Mol Sci. 2022;23(2).","DOI":"10.3390\/ijms23020852"},{"issue":"3","key":"1160_CR2","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1272\/jnms.JNMS.2022_89-310","volume":"89","author":"S SHINJI","year":"2022","unstructured":"Shinji S, Yamada T, Matsuda A, et al. Recent Advances in the Treatment of Colorectal Cancer: A Review [J]. J Nippon Med Sch. 2022;89(3):246\u201354.","journal-title":"J Nippon Med Sch"},{"key":"1160_CR3","doi-asserted-by":"crossref","unstructured":"Zhang C, Stampfl-Mattersberger M, Ruckser R et al. [Colorectal cancer] [J]. Wien Med Wochenschr. 2023;173(9\u201310):216\u2009\u2013\u200920.","DOI":"10.1007\/s10354-022-00975-6"},{"key":"1160_CR4","doi-asserted-by":"crossref","unstructured":"Lim C K, Bronson P G, Varade J, et al. STXBP6 and B3GNT6 Genes are associated with selective IgA deficiency [J]. Front Genet. 2021;12:736235.","DOI":"10.3389\/fgene.2021.736235"},{"key":"1160_CR5","doi-asserted-by":"crossref","unstructured":"Ghandour F, Green K D Jaine, et al. Novel ganglion cell marker B3GNT6: A step forward in Hirschsprung\u2019s disease diagnosis [J]. Pathol Res Pract. 2025;266:155780.","DOI":"10.1016\/j.prp.2024.155780"},{"issue":"4","key":"1160_CR6","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1002\/cam4.5096","volume":"12","author":"P CAO","year":"2023","unstructured":"Cao P, Wu Y, Sun D, et al. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation [J]. Cancer Med. 2023;12(4):4405\u201320.","journal-title":"Cancer Med"},{"issue":"1","key":"1160_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12957-022-02561-x","volume":"20","author":"S XIAO","year":"2022","unstructured":"Xiao S, Yang C, Zhang Y, et al. Downregulation of B3GNT6 is a predictor of poor outcomes in patients with colorectal cancer [J]. World J Surg Oncol. 2022;20(1):110.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"1160_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","volume":"9","author":"Q LI","year":"2024","unstructured":"Li Q, Geng S. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy [J]. Signal Transduct Target Ther. 2024;9(1):266.","journal-title":"Signal Transduct Target Ther"},{"key":"1160_CR9","doi-asserted-by":"crossref","unstructured":"Hoshida T, Tsubaki M, Takeda T, et al. Oxaliplatin and 5-fluorouracil promote epithelial-mesenchymal transition via activation of KRAS\/ERK\/NF-\u03baB pathway in KRAS-mutated colon cancer cells [J]. Mol Cell Biochem; 2024.","DOI":"10.1007\/s11010-024-05157-z"},{"issue":"18","key":"1160_CR10","doi-asserted-by":"publisher","first-page":"7903","DOI":"10.7150\/thno.76873","volume":"12","author":"YD LUO","year":"2022","unstructured":"Luo YD, Liu X Y Fangl, et al. Mutant Kras and mTOR crosstalk drives hepatocellular carcinoma development via PEG3\/STAT3\/BEX2 signaling [J]. Theranostics. 2022;12(18):7903\u201319.","journal-title":"Theranostics"},{"issue":"1","key":"1160_CR11","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1080\/21691401.2019.1673764","volume":"47","author":"Y LI","year":"2019","unstructured":"Li Y, Yu P, Zou Y, et al. KRas-ERK signalling promotes the onset and maintenance of uveal melanoma through regulating JMJD6-mediated H2A.X phosphorylation at tyrosine 39 [J]. Artif Cells Nanomed Biotechnol. 2019;47(1):4257\u201365.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"1160_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13046-018-0818-z","volume":"37","author":"Y SUN","year":"2018","unstructured":"Sun Y, Peng W, He W, et al. Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer [J]. J Exp Clin Cancer Res. 2018;37(1):166.","journal-title":"J Exp Clin Cancer Res"},{"issue":"21","key":"1160_CR13","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.1158\/0008-5472.CAN-19-0145","volume":"79","author":"M PELULLO","year":"2019","unstructured":"Pelullo M, Nardozza F, Zema S, et al. Kras\/ADAM17-Dependent Jag1-ICD Reverse Signaling Sustains Colorectal Cancer Progression and Chemoresistance [J]. Cancer Res. 2019;79(21):5575\u201386.","journal-title":"Cancer Res"},{"key":"1160_CR14","doi-asserted-by":"crossref","unstructured":"Khan S, Kwak Y T Pengl, et al. NLRP12 downregulates the Wnt\/\u03b2-catenin pathway via interaction with STK38 to suppress colorectal cancer [J]. J Clin Invest. 2023;133(19).","DOI":"10.1172\/JCI166295"},{"issue":"1","key":"1160_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13046-021-02229-6","volume":"41","author":"S DONG","year":"2022","unstructured":"DONG S, LIANG S, CHENG Z, et al. ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer [J]. J Exp Clin Cancer Res. 2022;41(1):15.","journal-title":"J Exp Clin Cancer Res"},{"key":"1160_CR16","doi-asserted-by":"crossref","unstructured":"Underwood P W, Ruff S M, Pawlik TM. Update on targeted therapy and immunotherapy for metastatic colorectal cancer [J]. Cells. 2024;13(3).","DOI":"10.3390\/cells13030245"},{"issue":"12","key":"1160_CR17","doi-asserted-by":"publisher","first-page":"9845","DOI":"10.1007\/s11033-023-08854-y","volume":"50","author":"SS RANJBARY A G, BAGHERZADEH A, SABBAG","year":"2023","unstructured":"Ranjbary A G, Bagherzadeh A, Sabbaghi SS, et al. Chlorogenic acid induces apoptosis and cell-cycle arrest in colorectal cancer cells [J]. Mol Biol Rep. 2023;50(12):9845\u201357.","journal-title":"Mol Biol Rep"},{"issue":"4","key":"1160_CR18","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1080\/10495398.2021.2025066","volume":"34","author":"MONDALS RAJ S R, D N D","year":"2023","unstructured":"Raj S R, D N D Mondals, et al. Expression analysis of pro-apoptotic BAX and anti-apoptotic BCL-2 genes in relation to lactation performance in Deoni and Holstein Friesian crossbred cows [J]. Anim Biotechnol. 2023;34(4):1354\u201361.","journal-title":"Anim Biotechnol"},{"issue":"1","key":"1160_CR19","doi-asserted-by":"publisher","first-page":"19477","DOI":"10.1038\/s41598-023-46521-1","volume":"13","author":"L RAN","year":"2023","unstructured":"Ran L, Mou X. ADORA2A promotes proliferation and inhibits apoptosis through PI3K\/AKT pathway activation in colorectal carcinoma [J]. Sci Rep. 2023;13(1):19477.","journal-title":"Sci Rep"},{"issue":"1","key":"1160_CR20","doi-asserted-by":"publisher","first-page":"13647","DOI":"10.1038\/s41598-025-98266-8","volume":"15","author":"F XIAOXIA","year":"2025","unstructured":"Xiaoxia F, Rui L, Meiru C, et al. CD147 regulates the Rap1 signaling pathway to promote proliferation, migration, and invasion, and inhibit apoptosis in colorectal cancer cells [J]. Sci Rep. 2025;15(1):13647.","journal-title":"Sci Rep"},{"issue":"8","key":"1160_CR21","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J DEBNATH","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer [J]. Nat Rev Mol Cell Biol. 2023;24(8):560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"1160_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41419-021-03722-8","volume":"12","author":"L JIN","year":"2021","unstructured":"Jin L, Chen Y, Cheng D, et al. YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression [J]. Cell Death Dis. 2021;12(5):457.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1160_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41392-024-01787-3","volume":"9","author":"CHEN R X","year":"2024","unstructured":"Chen R X, Xu S D, Deng M H, et al. Mex-3 RNA binding family member A (MEX3A)\/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy [J]. Signal Transduct Target Ther. 2024;9(1):80.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"1160_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41419-024-07057-y","volume":"15","author":"D WANG","year":"2024","unstructured":"Wang D, LI Y, Chang W, et al. CircSEC24B activates autophagy and induces chemoresistance of colorectal cancer via OTUB1-mediated deubiquitination of SRPX2 [J]. Cell Death Dis. 2024;15(9):693.","journal-title":"Cell Death Dis"},{"issue":"7","key":"1160_CR25","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/1354750X.2022.2102211","volume":"27","author":"CHANGLC FAN C W","year":"2022","unstructured":"Fan C W Changlc, Tseng W K, et al. The tumour\/normal tissue ratio of Keap1 protein is a predictor for lymphovascular invasion in colorectal cancer: a correlation study between the Nrf2 and KRas pathways [J]. Biomarkers. 2022;27(7):701\u20137.","journal-title":"Biomarkers"},{"issue":"6","key":"1160_CR26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrc1097","volume":"3","author":"M Malumbres","year":"2003","unstructured":"Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer. 2003;3(6):459\u201365. https:\/\/doi.org\/10.1038\/nrc1097.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1160_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13046-018-0818-z","volume":"37","author":"Y Sun","year":"2018","unstructured":"Sun Y, Peng W, He W, Luo M, Chang G, Shen J, Zhao X, Hu Y. Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer. J Exp Clin Cancer Res. 2018;37(1):166. https:\/\/doi.org\/10.1186\/s13046-018-0818-z.","journal-title":"J Exp Clin Cancer Res"},{"issue":"15","key":"1160_CR28","doi-asserted-by":"publisher","first-page":"12802","DOI":"10.1074\/jbc.M112457200","volume":"277","author":"T Iwai","year":"2002","unstructured":"Iwai T, Inaba N, Naundorf A, Zhang Y, Gotoh M, Iwasaki H, Kudo T, Togayachi A, Ishizuka Y, Nakanishi H, Narimatsu H. Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans. J Biol Chem. 2002;277(15):12802\u20139. https:\/\/doi.org\/10.1074\/jbc.M112457200.","journal-title":"J Biol Chem"},{"issue":"5","key":"1160_CR29","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1007\/s11010-024-05157-z","volume":"480","author":"T Hoshida","year":"2025","unstructured":"Hoshida T, Tsubaki M, Takeda T, Asano R, Choi IH, Takimoto K, Inukai A, Imano M, Tanabe K, Nagai N, Nishida S. Oxaliplatin and 5-fluorouracil promote epithelial-mesenchymal transition via activation of KRAS\/ERK\/NF-\u03baB pathway in KRAS-mutated colon cancer cells. Mol Cell Biochem. 2025;480(5):2985\u201399. https:\/\/doi.org\/10.1007\/s11010-024-05157-z.","journal-title":"Mol Cell Biochem"}],"container-title":["BMC Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12896-026-01160-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01160-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12896-026-01160-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:57:52Z","timestamp":1783468672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12896-026-01160-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1160"],"URL":"https:\/\/doi.org\/10.1186\/s12896-026-01160-y","relation":{},"ISSN":["1472-6750"],"issn-type":[{"value":"1472-6750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was approved by the Ethics Committee of Jiangsu Cancer Hospital (Approval no. 2022\u2009\u2212\u2009715) in compliance with the Helsinki Declaration. Written informed consent was obtained before the operation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients agreed for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}